 |
|
Thyrotropin Receptor Autoantibody Assessment in Thyroid Eye Disease: Does the Assay Type Matter?
Malik Moledina, Jonathan Roos, Rachna Murthy
Korean J Ophthalmol. 2023;37(2):147-156. Published online 2023 Apr 5 DOI: https://doi.org/10.3341/kjo.2022.0131
|
|
Citations to this article as recorded by
 Recurrent Graves' Disease Following Near-Total Thyroidectomy: A Case Report and Literature Review
Lakshmi P Menon, Syeda Naqvi, Jhansi Maradana, Dinesh Edem
Cureus.2024;[Epub] CrossRef The changing landscape of thyroid eye disease: current clinical advances and future outlook
Malik Moledina, Erika M. Damato, Vickie Lee
Eye.2024; 38(8): 1425. CrossRef Thyroid stimulating immunoglobulin concentration is associated with disease activity and predicts response to treatment with intravenous methylprednisolone in patients with Graves’ orbitopathy
Gijsbert J. Hötte, P. Martijn Kolijn, Maaike de Bie, Ronald O. B. de Keizer, Marco Medici, Kim van der Weerd, P. Martin van Hagen, Dion Paridaens, Willem A. Dik
Frontiers in Endocrinology.2024;[Epub] CrossRef Role of diffusion tensor imaging of extra ocular muscles and orbital fat in Graves’s ophthalmopathy and relation to disease activity
Manar Mansour Hussein, Mohamed Ghonem Mohamed, Amany Abdel Hamid Mousa, Azza Abd El Baky Baiomy, Ahmed Abd El Khalek Abdel Razek, Mohamed Roshdi Abd El Ghani
Egyptian Journal of Radiology and Nuclear Medicine.2024;[Epub] CrossRef Effect of intravenous methylprednisolone on serum antibody levels in thyroid eye disease
Chaeyeon Lee, Jung Eun Lee, Kyunga Kim, Kyung In Woo
British Journal of Ophthalmology.2024; : bjo-2024-325180. CrossRef
|